Chemomab to Present at Oppenheimer's Virtual Rare and Orphan Disease Summit USA - English Share this article Share this article TEL AVIV, Israel, May 12, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced that the company's CEO, Dr. Adi Mor will present a corporate update at Oppenheimer's virtual Rare and Orphan Disease Summit on May 21 st, 2021. Webcast link may be accessed here. The presentation will be availab...